LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Search

Avalo Therapeutics

Închisă

9.7 3.63

Rezumat

Modificarea prețului

24h

Curent

Minim

8.95

Maxim

9.93

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+240.14 upside

Avalo Therapeutics Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 oct. 2024, 23:50 UTC

Acțiuni populare

Stocks to Watch: Tesla, CSX, Alcoa

16 oct. 2024, 23:30 UTC

Achiziții, Fuziuni, Preluări

Discover Financial, SEC Working to Resolve Misclassification Matter -- Update

16 oct. 2024, 20:35 UTC

Câștiguri

CSX Posts Higher Revenue, Profit in 3Q on Increased Volume

16 oct. 2024, 23:59 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

16 oct. 2024, 23:59 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Woodside's LNG Deal Edges Ammonia Play, Bull Says -- Market Talk

16 oct. 2024, 23:53 UTC

Market Talk

Gold Steady Ahead of Key U.S. Economic Data -- Market Talk

16 oct. 2024, 23:50 UTC

Market Talk

Santos's Pikka Cost Rise Expected, But Builds Debt Pain -- Market Talk

16 oct. 2024, 22:46 UTC

Top știri

RTX Agrees to More Than $950 Million in Penalties to Settle Qatar Bribery, Contract Fraud Charges -- 2nd Update

16 oct. 2024, 22:33 UTC

Top știri

RTX Agrees to More Than $950 Million in Penalties to Settle Qatar Bribery, Contract Fraud Charges -- Update

16 oct. 2024, 22:18 UTC

Top știri

Elon Musk Taps Longtime Aide to Oversee Tesla's Operations in North America, Europe, Sources Say -- WSJ

16 oct. 2024, 21:32 UTC

Câștiguri

Morgan Stanley's Bumper Earnings Power Stock to Record High -- Barrons.com

16 oct. 2024, 21:20 UTC

Top știri

China Security Group Urges Review of Intel's Chips as Tech Tension With U.S. Rises -- 2nd Update

16 oct. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 oct. 2024, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

16 oct. 2024, 20:16 UTC

Top știri

Dow Edges Up; Morgan Stanley Gains on Strong Earnings Headline -- WSJ

16 oct. 2024, 20:12 UTC

Câștiguri

Kinder Morgan Cites Lower Than Budgeted Commodity Prices and Start-Up Delays on RNG Facilities >KMI

16 oct. 2024, 20:11 UTC

Câștiguri

Kinder Morgan Expects Adj EBITDA to Be Up 5% and Adj EPS to Be Up 9% for FY Vs 2023 >KMI

16 oct. 2024, 20:11 UTC

Câștiguri

Kinder Morgan Now Expects to Be Below Budget on Adj EBITDA by About 2% and on Adj EPS by About 4% >KMI

16 oct. 2024, 20:10 UTC

Câștiguri

Kinder Morgan Expects to Declare Dividends of $1.15 Per Shr for 2024 >KMI

16 oct. 2024, 20:10 UTC

Câștiguri

Kinder Morgan Budgeted 2024 DCF of $5 B, or $2.26 Per Share >KMI

16 oct. 2024, 20:10 UTC

Câștiguri

Kinder Morgan Project Backlog at End of 3Q Was $5.1 B >KMI

16 oct. 2024, 20:07 UTC

Câștiguri

Kinder Morgan: Final Investment Decision Reached for Gulf Coast Express Pipeline Expansion >KMI

16 oct. 2024, 20:06 UTC

Câștiguri

CSX Corp: 4Q Volume Expected to Grow Modestly>CSX

16 oct. 2024, 20:05 UTC

Câștiguri

CSX Corp: Lower revenue, Storm Impacts May Reduce Sequential Operating Margin in 4Q, Limiting 2H Margin Growth >CSX

16 oct. 2024, 20:05 UTC

Câștiguri

Kinder Morgan 3Q Rev $3.7B >KMI

16 oct. 2024, 20:05 UTC

Câștiguri

Kinder Morgan 3Q Adj EPS 25c >KMI

16 oct. 2024, 20:05 UTC

Câștiguri

Kinder Morgan 3Q EPS 28c >KMI

16 oct. 2024, 20:05 UTC

Câștiguri

Kinder Morgan 3Q Net $625M >KMI

16 oct. 2024, 20:05 UTC

Câștiguri

Kinder Morgan Sees FY EPS $1.22 >KMI

16 oct. 2024, 20:05 UTC

Câștiguri

Kinder Morgan Sees FY Net $2.7B >KMI

Comparație

Modificare preț

Avalo Therapeutics Așteptări

Obiectiv de preț

By TipRanks

240.14% sus

Prognoză pe 12 luni

Medie 35 USD  240.14%

Maxim 35 USD

Minim 35 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAvalo Therapeutics - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

$